Skip to main content
Premium Trial:

Request an Annual Quote

Thermo Fisher Scientific Ion Torrent Oncomine Myeloid MRD Assay

Thermo Fisher Scientific has launched the Ion Torrent Oncomine Myeloid MRD Assay, a next-generation sequencing (NGS)-based test for research in myeloid measurable residual disease (MRD) from ​blood and bone marrow samples. According to Thermo Fisher, the assay enables sensitive variant detection as low as 0.05 percent allele frequency for key DNA mutations in 33 genes and evaluation of more than 900 isoforms in 43 RNA fusion driver genes. The end-to-end workflow can deliver results in as little as two days with an integrated informatics pipeline and reporting tool that can help to minimize user hands-on time, the company said.